Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Investigating the Neurophysiology of the Motor System and the Feasibility of Vagus Nerve Stimulation in Functional Neurological Disorder (FND) (TMS-VNS)

16 luglio 2026 aggiornato da: University of Fribourg

Investigating the Neurophysiology of the Motor System and the Feasibility of Vagus Nerve Stimulation in Functional Neurological Disorder (FND): a Randomized, Sham-controlled Study

This clinical study will test if adding a non-invasive stimulation of the vagus nerve through the ear during physiotherapy brings an improvement to FND (Functional Neurological Disorder) patients with motor symptoms.

First, the investigators will test the normal functioning of the motor regions of the brain in FND patients and in healthy volunteers for comparison, using a painless method called TMS (Transcranial Magnetic Stimulation). Then, the investigators will further test how brain regions communicate with each other in FND patients, using fMRI (functional Magnetic Resonance Imaging, also painless). Additionally, the investigators will ask both FND patients and healthy volunteers to answer questions about their health and wellbeing, and will assess the exact symptoms of FND patients. The FND patients will then be assigned to two groups randomly, and neither they nor the researchers will know in which group they are. Both groups will do 5 sessions of their usual physiotherapy - one group with a real stimulation of the vagus nerve, and the other group with a fake stimulation. This is important to obtain reliable results. At the end, both groups of patients will be tested again to see if the way brain regions communicate with each other has changed. They will also answer again questions about their health and wellbeing, and their symptoms will be assessed again, to see if any changes happen. The results of the two groups of patients will be compared to isolate the effects of vagus nerve stimulation from the effects of physiotherapy alone.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The main goal of this project is to better understand the neurophysiology of the motor system and the role of attention in Functional Neurological Disorder (FND) and to explore the physiological effects of a novel non-invasive treatment option for this disorder.

To this end, several methods will be employed: non-invasive brain stimulation (using Transcranial Magnetic Stimulation, TMS), neuroimaging (fMRI), transdermal auricular vagus nerve stimulation (taVNS), clinical assessments and questionnaires.

The study consists of 2 experiments, each with specific objectives.

Primary objective:

The primary objective of this study is to assess the effects of taVNS, as an adjunctive intervention to standard physical therapy, on the quality of life in FND patients.

Secondary objectives:

Experiment 1

  1. Assess baseline neurophysiological differences of the motor system at rest and under different attentional demands, between FND patients and healthy participants.
  2. Compare the motor behaviour of the upper limb (index finger) under different attentional demands, in FND patients and healthy participants.
  3. Explore the role of symptom severity, mood, physical health, and interoception (the perception of bodily signals), assessed by questionnaires, in the modulation of motor system neurophysiology in FND patients and healthy participants.
  4. Explore the relationship between neurophysiological (point 1) and behavioral (point 2) outcomes, and the outcomes of clinical and psychological scores measured (point 3).

Experiment 2

  1. Assess the feasibility of the taVNS intervention as an adjunctive treatment in FND.
  2. Determine whether adding taVNS to standard physical therapy improves clinical outcomes (motor symptoms) in FND patients, assessed by clinical scores (CGI, sFMDRS).
  3. Explore changes in self-reported measures of mood, stress, physical health and interoception (the perception of bodily signals), assessed by questionnaires, after taVNS in FND patients.
  4. Explore changes in upper limb strength, measured by a grip strength test with hand-held dynamometer under different starting conditions (pressing freely and pressing after a cue), before, during and after taVNS in FND.
  5. Assess the effect of taVNS on heart rate and heart rate variability (HRV) in FND patients.
  6. Analyse the modulation of brain network connectivity via fMRI at rest and during a behavioural task (emotion-motion task), before and after taVNS in FND patients.
  7. Explore the relationship between neuroimaging (point 6), behavioral (point 2) outcomes, and the outcomes of clinical and psychological scores measured (point 3).

An additional outcome will explore the relationship between the outcomes of Experiment 1 and Experiment 2 to assess the prognostic potential of the outcomes of Experiment 1.

Tipo di studio

Interventistico

Iscrizione (Stimato)

68

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

  • Svizzera
    • Canton of Fribourg
      • Fribourg, Canton of Fribourg, Svizzera, 1700
        • University of Fribourg
        • Contatto:
        • Sub-investigatore:
          • Michael Mouthon, PhD
        • Contatto:
        • Sub-investigatore:
          • Cristina Concetti, PhD
        • Sub-investigatore:
          • Julia Paratte, Master
        • Sub-investigatore:
          • Janne Magnin, Bachelor
        • Sub-investigatore:
          • Sarah Botman, Bachelor

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria for FND patients:

  • Over 18 years of age.
  • Capable of judgement.
  • Willing to participate in the study (by signing the informed consent form).
  • FND diagnosis by a certified neurologist or psychiatrist.
  • Motor FND symptoms in the upper limb in the form of tremor or weakness.
  • Participating in physiotherapy for FND.

Exclusion Criteria for FND patients:

  • Severe neuropsychiatric comorbidities.
  • Pregnancy or breastfeeding.
  • Prior knowledge on the effects of attention on the motor system.
  • Prior history of epilepsy or epileptic seizures in the person and their family.
  • Severe claustrophobia.
  • Implanted medical devices.
  • Ear anatomy incompatible with the taVNS device (e.g. cauliflower ear).
  • Previous use of taVNS.
  • Substance abuse.
  • Simultaneous participation in another investigation involving an investigational drug or a MD.
  • Enrolment of the PI and their dependent persons.

Inclusion Criteria for healthy volunteers:

  • Over 18 years of age.
  • Capable of judgement.
  • Willing to participate in the study (by signing the informed consent form).

Exclusion Criteria for healthy volunteers:

  • Neurological or neuropsychiatric or movement disorders.
  • Pregnancy or breastfeeding.
  • Prior knowledge on the effects of attention on the motor system.
  • Prior history of epilepsy or epileptic seizures in the person and their family.
  • Substance abuse.
  • Simultaneous participation in another investigation involving an investigational drug or a MD.
  • Enrolment of the PI and their dependent persons.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione fattoriale
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Patient VNS stimulation intervention
FND patients received a 30 minutes VNS stimulation for 5 sessions during their usual physiotherapy course treatment.
Dispositivo: Vagial Nerve Stimulation (VNS) active stimulation
taVNS sends gentle electric stimuli to the vagus nerve branch located in the outer ear, which are transmitted to the nucleus of the solitary tract in the brainstem, and from there to the rest of the brain. The electrode site is the cymba conchae in in the outer ear. VNS thus acts to enhance the activity of the parasympathetic nervous system.
Altri nomi:
  • attivo
  • taVNS
  • TVNS
Comparatore fittizio: Patient VNS sham intervention
FND patients received a 30 minutes VNS sham for 5 sessions during their usual physiotherapy course treatment.
Dispositivo: Vagial Nerve Stimulation (VNS) sham stimulation
taVNS sends gentle electric stimuli for several minutes, during which time the patient will feel a tickling sensation. Then, for the rest of the session, the hidden device will be switched off (there will be no stimulation).
Altri nomi:
  • finto
  • taVNS
  • TVNS
Nessun intervento: Heathy control without intervention

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Self-reported quality of life
Lasso di tempo: For each intervention session at weeks 3, 4, 5, 6, 7
The change in self-reported quality of life, measured through intervention sessions with the Euro Quality of Life questionnaire (EQ-5D-5L), compared between the active stimulation group and the sham stimulation group. This questionnaire includes 5 subscales (1-best, 5-worstest) about mobility, self-care, usual activities, pain/discomfort, anxiety/depression. In addition it includes a continue scale evaluation (0-worst to 100-best) about the patient evaluation on his health.
For each intervention session at weeks 3, 4, 5, 6, 7

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Neurophysiology investigation of the pathology by comparing Motor-Evoked Potential between FND patients and healthy participant
Lasso di tempo: At TMS session, week 2 for patients and week 0 for heathy controls
The study will examine cortical inhibition as measured by motor-evoked potentials (MEPs) during a short-interval intracortical inhibition (SICI) transcranial magnetic stimulation (TMS) protocol (single-pulse and paired-pulse). The investigators will examine how the outcome differs under different attentional demands in patients with functional neurological disorder (FND) and healthy participants.
At TMS session, week 2 for patients and week 0 for heathy controls
Neurophysiology investigation of the pathology by comparing resting motor threshold between FND patients and healthy participant
Lasso di tempo: At TMS session, week 2 for patients and week 0 for heathy controls
The study will examine the resting motor threshold (in millivolts), which is the level of stimulation required to trigger motor-evoked potentials using a single-pulse transcranial magnetic stimulation (TMS) technique. The investigators will examine how this outcome differs between patients with functional neurological disorder (FND) and healthy participants.
At TMS session, week 2 for patients and week 0 for heathy controls
Comparison of motor performance between patients and healthy controls
Lasso di tempo: At TMS session, week 2 for patients and week 0 for heathy controls
The differences in motor performance between FND patients and healthy controls were measured by the accuracy with which they maintained an isometric contraction during index finger abduction at 10% of maximum force.
At TMS session, week 2 for patients and week 0 for heathy controls
Satisfaction rating of patients on the intervention
Lasso di tempo: At the end of the last intervention session at week 7
Patients will be asked to rate their satisfaction after the intervention on a scale from 1 to 10.
At the end of the last intervention session at week 7
Changes in upper limb strength, measured by a grip strength test under different starting conditions, before, during and after taVNS intervention.
Lasso di tempo: weeks 2, 3, 4, 5, 6, 7
Grip strength measured with hand-held dynamometer (Jamar). The different starting condition was pressing freely or pressing after a cue.
weeks 2, 3, 4, 5, 6, 7
Changes in parasympathetic tone measured by heart rate variability
Lasso di tempo: During intervention sessions at weeks 3, 4, 5, 6, 7
A sport belt would continuously record the heart rate of patients during physiotherapy sessions.
During intervention sessions at weeks 3, 4, 5, 6, 7
Change in functional connectivity, measured by resting-state fMRI
Lasso di tempo: weeks 0, 8
Study the differences in functional connectivity of the brain in patients at the beginning and end of the experimental protocol.
weeks 0, 8
General heath condition questionnaire
Lasso di tempo: week 0
Use of the questionnaire SF-36 (Medical Outcomes Study Short Form Health Survey) fill by participants to evaluate their heath condition (score between 0-bad and 100-good).
week 0
Study the evolution of symptom severity score
Lasso di tempo: weeks 1, 2, 3, 4, 5, 6, 7, 8
The patients completed the Subjective Evaluation of Symptom Severity (SSS) questionnaire, which uses a continuous scale ranging from 0 (no symptoms) to 100 (the most severe symptoms experienced) for each session. For the intervention sessions, they fill it twice (before and after the intervention).
weeks 1, 2, 3, 4, 5, 6, 7, 8
Study evolution of perceived stress
Lasso di tempo: weeks 1, 2, 3, 4, 5, 6, 7, 8
The patients completed the Perceived Stress Scale (PSS) questionnaire with 4 items, which uses a score from 4 (no stress) to 20 (extremely stressed). For the intervention sessions, they fill it twice (before and after the intervention).
weeks 1, 2, 3, 4, 5, 6, 7, 8
Study the evolution of the clinical global impression score
Lasso di tempo: weeks 1, 2, 3, 4, 5, 6, 7, 8
The investigator will assess the severity of the patient's symptoms using a scale ranging from 0 (normal, not at all unwell) to 7 (among the most severely unwell) at each session. For the intervention sessions, the evaluation is done twice (before and after the intervention).
weeks 1, 2, 3, 4, 5, 6, 7, 8
Study the evolution of depression evaluation
Lasso di tempo: weeks 2, 8
The patients completed the Beck Depression Inventory (BDI-II) questionnaire before and after the intervention period. The questionnaire uses a score ranging from 0 (not depressed) to 63 (extremely depressed).
weeks 2, 8
Study the evolution of stress evaluation
Lasso di tempo: weeks 2, 8
The patients completed the State-Trait Anxiety Inventory (STAI) questionnaire before and after the intervention period. The questionnaire uses a score ranging from 20 (not stressed) to 80 (extremely stressed) for the state and the trait separetely.
weeks 2, 8
Study the evolution of interoception evaluation
Lasso di tempo: weeks 0, 8
The patients completed the Multidimensional Assessment of Interoceptive Awareness (MAIA) questionnaire before and after the whole protocol. The questionnaire uses a score ranging from 0 (poor interoceptive sensitivity) to 40 (excellent interoceptive sensitivity).
weeks 0, 8
Study the evolution of functional movement disorders rating scale
Lasso di tempo: weeks 0, 8
The investigator performed Simplified Functional Movement Disorders Rating Scale (sFMDRS) questionnaire before and after the intervention period. The questionnaire uses a score ranging from 0 (no symptoms) to 48 (extremely symptomatic).
weeks 0, 8
Satisfaction rating of physiotherapists on the intervention
Lasso di tempo: At the end of the last intervention session at week 7
Physiotherapists will be asked to rate their satisfaction after the intervention on a scale from 1 to 10.
At the end of the last intervention session at week 7

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

University of Fribourg

Collaboratori

Hôpital Cantonal de Fribourg

Investigatori

  • Direttore dello studio: Cristina Concetti, PhD, University of Fribourg

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 luglio 2026

Completamento primario (Stimato)

1 luglio 2028

Completamento dello studio (Stimato)

1 dicembre 2028

Date di iscrizione allo studio

Primo inviato

24 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 luglio 2026

Primo Inserito (Effettivo)

17 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 2026-D0047

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Participants had the option of signing an informed consent form to allow their coded data to be shared with the scientific community.

At the end of the project, the de-identified raw data would be published in a public repository on the Zenodo platform.

Periodo di condivisione IPD

The public repositories would be made available to the public after the publication date of the relevant scientific article.

Tipo di informazioni di supporto alla condivisione IPD

  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Vagial Nerve Stimulation (VNS) active stimulation

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Uganda

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi